Quality improvements in prostate radiotherapy: Outcomes and impact of comprehensive quality assurance during the TROG 03.04 ‘RADAR’ trial

Introduction The T rans‐ T asman Radiation Oncology Group 03.04 ‘Randomised Androgen Deprivation and Radiotherapy’ multicentre prostate cancer trial examined the optimal duration of androgen deprivation in combination with dose‐escalated radiotherapy. Rigorous quality assurance ( QA ) processes were undertaken to ensure the validity and reliability of the radiation therapy treatment plan data. Method QA processes included a planning benchmarking...